{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T22:48:31Z","timestamp":1696891711709},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CDTCNSND"],"published-print":{"date-parts":[[2003,8,1]]},"DOI":"10.2174\/1568007033482823","type":"journal-article","created":{"date-parts":[[2005,3,25]],"date-time":"2005-03-25T00:10:19Z","timestamp":1111709419000},"page":"207-212","source":"Crossref","is-referenced-by-count":9,"title":["Validation of GABAA Receptor Subtypes as Potential Drug Targets by Using Genetically Modified Mice"],"prefix":"10.2174","volume":"2","author":[{"given":"Thomas","family":"Rosahl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Current Drug Target -CNS & Neurological Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/91718","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T10:05:52Z","timestamp":1448273152000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=1568-007X&volume=2&issue=4&spage=207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,8,1]]},"references-count":0,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,8,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1568007033482823","relation":{},"ISSN":["1568-007X"],"issn-type":[{"value":"1568-007X","type":"print"}],"subject":[],"published":{"date-parts":[[2003,8,1]]}}}